Not yet recruiting NCT06686940
Photoplethysmography (PPG) Algorithm With Smartwatch in Evaluation of Atrial Fibrillation Burden
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: intervention group.
- Who it may be relevant to
- Registry conditions: Atrial Fibrillation (AF). Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The purpose of this study is to evaluate the monitoring effect of a smart electrocardiogram watch based on the PPG algorithm on atrial fibrillation burden.
Interventions
- Device intervention group
The monitoring effect of a smart electrocardiogram watch based on the PPG algorithm on atrial fibrillation burden.
Primary outcome measures
- Primary outcome [Time frame: December 30, 2024 to Decemberr 30, 2034]
Eligibility criteria
Inclusion criteria
- Atrial fibrillation patients diagnosed by electrocardiogram
- Willing to use long-range electrocardiogram monitoring equipment
Exclusion criteria
1.Patients who are allergic to electronic devices or unable to wear watches
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
China · 1 center
- Beijing Anzhen Hospital — Beijing
Identifiers
NCT: NCT06686940 · KS2024100 · KS2024100